SYRE compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

SYRESpyre Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

SYRESpyre Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

SYRESpyre Therapeutics, Inc.

99.08▲+3.74%· post 92.00

Mkt cap$8.4BRevenue—Revenue—

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,416.42

ClosedNov 3 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 3 '26

SYRESpyre Therapeutics, Inc.

LLYELI Lilly & Co

99.08▲+3.74%post 92.00

Price

1,407.25▼−0.27%post 1,416.42

$8.4B

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

SYRE99.08▲+3.74%vsLLY1,407.25▼−0.27%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SYRE: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SYRE 5

—WuXi Biologics (Hong Kong)unlistedsupplier

—Paragonunlistedsupplier

—WuXi Biologicsunlistedsupplier

—Equiniti Trust Company LLC (f/k/a American Stock Transfer & Trust Company LLC)unlistedsupplier

1 more · SYRE chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

SYRE, solidLLY, dashed